DG Grahame‐Smith

591 total citations
25 papers, 478 citations indexed

About

DG Grahame‐Smith is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, DG Grahame‐Smith has authored 25 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pediatrics, Perinatology and Child Health, 9 papers in Psychiatry and Mental health and 6 papers in Molecular Biology. Recurrent topics in DG Grahame‐Smith's work include Pharmacological Effects and Toxicity Studies (5 papers), Bipolar Disorder and Treatment (4 papers) and Electrolyte and hormonal disorders (4 papers). DG Grahame‐Smith is often cited by papers focused on Pharmacological Effects and Toxicity Studies (5 papers), Bipolar Disorder and Treatment (4 papers) and Electrolyte and hormonal disorders (4 papers). DG Grahame‐Smith collaborates with scholars based in United Kingdom and Australia. DG Grahame‐Smith's co-authors include JK Aronson, D J Boullin, Helmut Hörtnagl, HF Woods, Philip J. Cowen, C Bunch, John Boutagy, Adrian L. Harris, David J. Harvey and C. W. Potter and has published in prestigious journals such as British Journal of Clinical Pharmacology and Clinical Science.

In The Last Decade

DG Grahame‐Smith

24 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
DG Grahame‐Smith United Kingdom 14 159 121 114 74 65 25 478
Dale G. Friend United States 14 129 0.8× 76 0.6× 83 0.7× 187 2.5× 56 0.9× 70 779
M. R. Lee United Kingdom 10 184 1.2× 145 1.2× 50 0.4× 56 0.8× 37 0.6× 19 599
F. Le Coz France 14 81 0.5× 149 1.2× 72 0.6× 54 0.7× 15 0.2× 23 468
Joann L. Data United States 10 149 0.9× 96 0.8× 101 0.9× 144 1.9× 85 1.3× 12 538
Montastruc Jl France 14 129 0.8× 78 0.6× 61 0.5× 160 2.2× 36 0.6× 87 686
Jan Idvall Sweden 11 77 0.5× 69 0.6× 91 0.8× 73 1.0× 53 0.8× 22 529
Yannick Plétan France 13 69 0.4× 97 0.8× 163 1.4× 80 1.1× 37 0.6× 27 561
J. Wemer Netherlands 12 193 1.2× 73 0.6× 33 0.3× 145 2.0× 43 0.7× 29 565
D. Arndts Germany 12 89 0.6× 79 0.7× 18 0.2× 63 0.9× 37 0.6× 27 414
D. F. Horrobin United Kingdom 14 88 0.6× 42 0.3× 72 0.6× 33 0.4× 47 0.7× 33 602

Countries citing papers authored by DG Grahame‐Smith

Since Specialization
Citations

This map shows the geographic impact of DG Grahame‐Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DG Grahame‐Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DG Grahame‐Smith more than expected).

Fields of papers citing papers by DG Grahame‐Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by DG Grahame‐Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DG Grahame‐Smith. The network helps show where DG Grahame‐Smith may publish in the future.

Co-authorship network of co-authors of DG Grahame‐Smith

This figure shows the co-authorship network connecting the top 25 collaborators of DG Grahame‐Smith. A scholar is included among the top collaborators of DG Grahame‐Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with DG Grahame‐Smith. DG Grahame‐Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grahame‐Smith, DG. (1991). Clinical pharmacology. Roles and responsibilities in academic research.. British Journal of Clinical Pharmacology. 32(2). 151–154. 1 indexed citations
2.
Aronson, JK, et al.. (1991). The effect of nifedipine on the disposition of strontium gluconate used as a kinetic marker for calcium in healthy volunteers.. British Journal of Clinical Pharmacology. 32(4). 441–445. 2 indexed citations
3.
4.
Wood, AJ, et al.. (1990). The effect of oral salbutamol on cation transport measured in vivo in healthy volunteers.. British Journal of Clinical Pharmacology. 30(3). 383–390. 3 indexed citations
5.
Wood, AJ, JK Aronson, C Bunch, & DG Grahame‐Smith. (1989). A study of the transport of lithium across the erythrocyte membrane in vivo and of the effects of the ion transport inhibitors digoxin and dipyridamole.. British Journal of Clinical Pharmacology. 27(6). 749–756. 5 indexed citations
6.
Bochner, Felix, et al.. (1986). Dose‐dependent inhibition of phosphoinositide metabolism in human platelets by aspirin in vitro and in vivo.. British Journal of Clinical Pharmacology. 22(4). 443–447. 2 indexed citations
7.
Aronson, JK, et al.. (1986). In vivo cation transport during short‐term and long‐term digoxin therapy.. British Journal of Clinical Pharmacology. 22(1). 27–30. 1 indexed citations
8.
Schächter, Michael, et al.. (1985). Increased platelet membrane [3H]‐LSD binding in patients on chronic neuroleptic treatment.. British Journal of Clinical Pharmacology. 19(4). 453–457. 18 indexed citations
9.
Cowen, Philip J., et al.. (1985). Plasma melatonin during desmethylimipramine treatment: evidence for changes in noradrenergic transmission.. British Journal of Clinical Pharmacology. 19(6). 799–805. 45 indexed citations
10.
Aronson, JK, et al.. (1981). Lack of effect of phenytoin on functions related to Na+,K+‐ATPase activity of the intact erythrocytes of epileptic patients.. British Journal of Clinical Pharmacology. 12(1). 79–81. 1 indexed citations
11.
Allen, R. S., et al.. (1981). The effects of neuroleptic drugs on 5‐hydroxytryptamine induced platelet aggregation in schizophrenic patients.. British Journal of Clinical Pharmacology. 11(3). 255–259. 18 indexed citations
12.
13.
14.
Aronson, JK, et al.. (1979). The characteristics of the binding of 12‐alpha‐[3H]‐digoxin to the membranes of intact human erythrocytes: relevance to digoxin therapy.. British Journal of Clinical Pharmacology. 8(2). 115–124. 23 indexed citations
15.
Harris, Adrian L., C. W. Potter, C Bunch, et al.. (1979). Pharmacokinetics of cytosine arabinoside in patients with acute myeloid leukaemia.. British Journal of Clinical Pharmacology. 8(3). 219–227. 59 indexed citations
16.
Boullin, D J, et al.. (1978). Platelet aggregation and chlorpromazine therapy.. British Journal of Clinical Pharmacology. 6(6). 538–540. 19 indexed citations
17.
Aronson, JK & DG Grahame‐Smith. (1977). Monitoring digoxin therapy: II. Determinants of the apparent volume of distribution.. British Journal of Clinical Pharmacology. 4(2). 223–227. 20 indexed citations
18.
Aronson, JK, et al.. (1977). Monitoring digoxin therapy: I. Plasma concentrations and an in vitro assay of tissue response.. British Journal of Clinical Pharmacology. 4(2). 213–221. 36 indexed citations
19.
Boullin, D J, et al.. (1975). Increased platelet aggregation responses to 5‐hydroxytryptamine in patients taking chlorpromazine.. British Journal of Clinical Pharmacology. 2(1). 29–35. 52 indexed citations
20.
Boullin, D J, et al.. (1975). Resuspension of platelets: enhanced 5‐hydroxytryptamine‐induced aggregation in chlorpromazine treated patients due to changes in platelet properties.. British Journal of Clinical Pharmacology. 2(1). 37–39. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dale G. Friend Breakdown of academic impact, for papers by M. R. Lee Breakdown of academic impact, for papers by F. Le Coz Breakdown of academic impact, for papers by Joann L. Data Breakdown of academic impact, for papers by Montastruc Jl Breakdown of academic impact, for papers by Jan Idvall Breakdown of academic impact, for papers by Yannick Plétan Breakdown of academic impact, for papers by J. Wemer Breakdown of academic impact, for papers by D. Arndts Breakdown of academic impact, for papers by D. F. Horrobin
Rankless by CCL
2026